Thalamus News and Research RSS Feed - Thalamus News and Research

The Thalamus is an area of the brain that helps process information from the senses and transmit it to other parts of the brain.
Researchers identify novel life-preserving circuit responsible for recognizing threats

Researchers identify novel life-preserving circuit responsible for recognizing threats

Our existence depends on a bit of evolutionary genius aptly nicknamed "fight or flight." But where in our brain does the alarm first go off, and what other parts of the brain are mobilized to express fear and remember to avoid danger in the future? [More]
Brain uses separate pathway to recall old fear memories

Brain uses separate pathway to recall old fear memories

People with anxiety disorders, such as post traumatic stress disorder (PTSD), often experience prolonged and exaggerated fearfulness. Now, an animal study suggests that this might involve disruption of a gradual shifting of brain circuitry for retrieving fear memories. Researchers funded by the National Institutes of Health have discovered in rats that an old fear memory is recalled by a separate brain pathway from the one originally used to recall it when it was fresh. [More]
CSHL researchers describe new pathway that controls fear memories in the mouse brain

CSHL researchers describe new pathway that controls fear memories in the mouse brain

Some people have no fear, like that 17-year-old kid who drives like a maniac. But for the nearly 40 million adults who suffer from anxiety disorders, an overabundance of fear rules their lives. Debilitating anxiety prevents them from participating in life's most mundane moments, from driving a car to riding in an elevator. [More]
Alim Louis Benabid, Mahlon DeLong jointly win 2014 Lasker-DeBakey Clinical Medical Research Award

Alim Louis Benabid, Mahlon DeLong jointly win 2014 Lasker-DeBakey Clinical Medical Research Award

French neurosurgeon Alim Louis Benabid and American neurologist Mahlon DeLong were recently named winners of the 2014 Lasker-DeBakey Clinical Medical Research Award for their roles in developing deep brain stimulation (DBS) for the treatment of Parkinson disease. [More]

Microscope objectives for ultra-deep biological imaging introduced by Olympus

Two dedicated microscope objectives optimized for deep, high-resolution imaging of life science specimens up to 8mm beneath the surface have been introduced by Olympus. [More]
Changes in the brain may explain premature babies' higher risk of neurodevelopmental disorders

Changes in the brain may explain premature babies' higher risk of neurodevelopmental disorders

Disturbances in the early stages of brain growth, such as preterm birth - when many of the brain's structures have not yet fully developed - appears to affect the brain's neuro-circuitry, which may explain premature babies' higher risk of neurodevelopmental disorders including ADHD and autism spectrum disorder. [More]
NeuroSigma, VA partner to evaluate eTNS system for TBI patients in Phase I clinical trial

NeuroSigma, VA partner to evaluate eTNS system for TBI patients in Phase I clinical trial

NeuroSigma, Inc., a California-based life sciences company focused on commercialization of its non-invasive Monarch eTNS System for the treatment of neurological and neuropsychiatric disorders, today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Veterans Affairs for a clinical trial to evaluate the benefits of non-invasive, external Trigeminal Nerve Stimulation (eTNS) for patients with traumatic brain injury (TBI) in a Phase I clinical trial. [More]
Brain structure changes differ between schizophrenia symptoms

Brain structure changes differ between schizophrenia symptoms

The specific areas of the brain with reduced grey matter in patients with schizophrenia differ according to whether they have predominant positive, negative or disorganised symptoms, research suggests. [More]
Researchers identify control mechanism for mood disorders

Researchers identify control mechanism for mood disorders

Researchers at University of California, San Diego School of Medicine have identified a control mechanism for an area of the brain that processes sensory and emotive information that humans experience as "disappointment." [More]

Unusual neural links between brainstem and injured cingulums following aneurysmal SAH

The cingulum is an important pathway for cholinergic innervation for the cerebral cortex. Many studies have reported connections between the cholinergic nuclei, especially between the cholinergic nuclei in the basal forebrain and those in the brainstem via the fornix and thalamus. [More]
Researchers reveal important clue for treating absence seizures

Researchers reveal important clue for treating absence seizures

A group of Korean researchers have succeeded in revealing a principle mechanism of a neural network in the human brain, which will provide an important clue to potential treatments for absence seizures. [More]
NIH-funded study explores how thalamic reticular nucleus influences consciousness

NIH-funded study explores how thalamic reticular nucleus influences consciousness

Ever wonder why it's hard to focus after a bad night's sleep? Using mice and flashes of light, scientists show that just a few nerve cells in the brain may control the switch between internal thoughts and external distractions. [More]
SWI provides information about pathophysiological changes of brain after acute hemorrphagic anemia

SWI provides information about pathophysiological changes of brain after acute hemorrphagic anemia

Acute hemorrhagic anemia can decrease blood flow and oxygen supply to brain, and affect its physiological function. Detecting changes in brain function in patients with acute hemorrhagic anemia is helpful for preventing neurological complications and evaluating therapeutic effects. [More]
NIH funds Phase II 90-subject pediatric clinical trial at UCLA

NIH funds Phase II 90-subject pediatric clinical trial at UCLA

NeuroSigma, Inc., a California-based life sciences company focused on commercialization of its non-invasive Monarch eTNS System for the treatment of neurological and neuropsychiatric disorders, today announced that the U.S. National Institutes of Health (NIH) has awarded UCLA a grant that funds a Phase II 90-subject pediatric clinical trial at the University of California, Los Angeles focused on the treatment of Attention Deficit Hyperactivity Disorder (ADHD) with NeuroSigma's external trigeminal nerve stimulation (eTNS) System. [More]
Brain circuit problem may contribute to auditory hallucinations of schizophrenia

Brain circuit problem may contribute to auditory hallucinations of schizophrenia

St. Jude Children's Research Hospital scientists have identified problems in a connection between brain structures that may predispose individuals to hearing the "voices" that are a common symptom of schizophrenia. The work appears in the June 6 issue of the journal Science. [More]
Biologists identify how T-type channels change electrochemical signaling of heart and brain cells

Biologists identify how T-type channels change electrochemical signaling of heart and brain cells

Biologists have discovered how an outer shield over T-type channels change the electrochemical signaling of heart and brain cells. Understanding how these shields work will help researchers eventually develop a new class of drugs for treating epilepsy, cardiovascular disease and cancer. [More]
Neuroinflammation levels higher in patients with chronic fatigue syndrome

Neuroinflammation levels higher in patients with chronic fatigue syndrome

Researchers at the RIKEN Center for Life Science Technologies, in collaboration with Osaka City University and Kansai University of Welfare Sciences, have used functional PET imaging to show that levels of neuroinflammation, or inflammation of the nervous system, are higher in patients with chronic fatigue syndrome than in healthy people. [More]
NeuroSigma gets approval to market Monarch eTNS System in Australia

NeuroSigma gets approval to market Monarch eTNS System in Australia

NeuroSigma, Inc., a California-based life-sciences company focused on commercialization of its non-invasive Monarch eTNS System for the treatment of neurological and neuropsychiatric disorders, today announced that it has received approval from the Therapeutic Goods Administration to market its Monarch eTNS System in Australia. [More]
Neurosurgeons use MRI-guided laser technology to treat deep brain tumor

Neurosurgeons use MRI-guided laser technology to treat deep brain tumor

Using a novel magnetic resonance imaging (MRI)-guided laser technology, neurosurgeons at UC San Diego Health System have successfully treated a malignant tumor deep inside a patient's brain. This is the first time that this FDA-approved laser-based treatment has been performed in California. [More]
Omega-3 supplements, sertraline could help prevent onset of depression and dementia in later life

Omega-3 supplements, sertraline could help prevent onset of depression and dementia in later life

A University of Sydney study is looking into the effectiveness of omega-3 supplements and the antidepressant, sertraline, in reducing depressive symptoms and cognitive decline in older people, in a bid to prevent the onset of depression and dementia in later life. [More]